Published in J Chromatogr on August 21, 1991
An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol (1994) 1.54
The Unified Medical Language System (UMLS) of the National Library of Medicine. J Am Med Rec Assoc (1990) 1.81
Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry. Biomed Mass Spectrom (1980) 1.22
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol (1989) 1.10
Mitochondrial abnormalities in inclusion-body myositis. Neurology (2006) 1.03
Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol (1995) 1.00
Mitochondrial DNA deletions in inclusion body myositis. Brain (1993) 0.99
Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metab Dispos (1984) 0.97
Myopathies associated with myosin heavy chain mutations. Acta Myol (2004) 0.97
Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromuscul Disord (2005) 0.95
Molecular cloning and characterization of spiggin. An androgen-regulated extraorganismal adhesive with structural similarities to von Willebrand Factor-related proteins. J Biol Chem (2001) 0.95
Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord (2009) 0.90
Bleeding, a side effect of fluoxetine. Am J Psychiatry (1992) 0.88
Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Hum Mutat (1997) 0.88
Inclusion body myositis. Curr Opin Neurol (1999) 0.85
A novel mutation in the mitochondrial tRNA(Phe) gene associated with mitochondrial myopathy. Neuromuscul Disord (2004) 0.84
Pharmacokinetics of intravenous terbutaline in asthmatic children. Dev Pharmacol Ther (1989) 0.84
Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. Scand J Immunol (2003) 0.84
Facial emotion recognition in myotonic dystrophy type 1 correlates with CTG repeat expansion. J Neurol Neurosurg Psychiatry (2006) 0.83
Merging, de-merging, and emerging at Deaconess Billings Clinic. Physician Exec (2000) 0.82
A novel heteroplasmic point mutation in the mitochondrial tRNA(Lys) gene in a sporadic case of mitochondrial encephalomyopathy: de novo mutation and no transmission to the offspring. Hum Mutat (1999) 0.82
Restricted access chromatographic sample preparation of low mass proteins expressed in human fibroblast cells for proteomics analysis. J Chromatogr A (2001) 0.82
Artifacts formed in the metabolic study of pethidine. Acta Pharm Suec (1978) 0.82
Mapping and characterization of 129 cosmids on human chromosome 11p. Somat Cell Mol Genet (1992) 0.81
Embryonic stem cells as a model for studying regulation of cellular differentiation. Theriogenology (1998) 0.81
Acute and temporary inhibition of thymidine kinase in mouse bone marrow cells after low-dose exposure. Int J Radiat Biol Relat Stud Phys Chem Med (1984) 0.81
Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects. Drug Metab Dispos (1987) 0.81
Physical training effects in myasthenia gravis. Arch Phys Med Rehabil (1993) 0.80
Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1. Eur J Neurol (2008) 0.80
Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ (1994) 0.80
Quantitative analysis of terbutaline by gas chromatography-mass spectrometry. Eur J Respir Dis Suppl (1984) 0.80
T cell receptor beta-chain repertoire in inclusion body myositis. J Neuroimmunol (1998) 0.79
Expression of Bcl-2 in inclusion body myositis. Acta Neurol Scand (2002) 0.78
Long-term survival of fetal porcine lateral ganglionic eminence cells in the hippocampus of rats. J Neurosci Res (1999) 0.78
Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy. J Neurol Neurosurg Psychiatry (1992) 0.78
Inclusion body myositis: morphological clues to correct diagnosis. Neuromuscul Disord (2002) 0.78
Kinetics of terbutaline in asthmatic children. Eur J Respir Dis Suppl (1984) 0.78
Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat. Drug Metab Dispos (1979) 0.77
Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids. Drug Metab Dispos (1987) 0.77
An environmentally regulated receptor for diamine oxidase modulates human endothelial cell/fibroblast histamine degradative uptake. J Biol Chem (1994) 0.76
Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol (1997) 0.76
Terbutaline in the treatment of preterm labour. Eur J Respir Dis Suppl (1984) 0.76
Centrolobular liver cell necrosis, myocardial infarction, and hyperamylasaemia after high dose corticosteroids. BMJ (1994) 0.75
A selected ion monitoring method for the determination of pethidine and norpethidine in plasma. Comparison with a gas chromatographic method using electron capture detection. Biomed Mass Spectrom (1978) 0.75
Determination of drug enantiomers in biological samples by coupled column liquid chromatography and liquid chromatography-mass spectrometry. J Chromatogr (1988) 0.75
Mass spectrometric identification of a new metabolite of pethidine. J Pharm Pharmacol (1975) 0.75
Limited T-cell receptor V gene usage in inclusion body myositis. Scand J Immunol (1996) 0.75
Single injection of terbutaline in term labor: placental transfer and effects on maternal and fetal carbohydrate metabolism. Am J Obstet Gynecol (1981) 0.75
Laboratory medicine: the precursors strike back. Acta Clin Belg (2011) 0.75
Mass spectrometry of pethidine and pethidine metabolites. A study utilizing specifically deuterated pethidine. Acta Pharm Suec (1974) 0.75
Radioimmunoassay and chemical ionization/mass spectrometry compared for plasma cortisol determination. Clin Chem (1982) 0.75
Synthesis and mass spectra of deuterium-labelled ketobemidone and of some potential ketobemidone metabolites. Acta Pharm Suec (1980) 0.75
Transfer of terbutaline into breast milk. Eur J Respir Dis Suppl (1984) 0.75
Bromination of 4-dimethylamino-3-methylphenol and related indoline and tetrahydroquinoline derivatives. Acta Pharm Suec (1973) 0.75
Fetal pig neural cells as a restorative therapy for neurodegenerative disease. Artif Organs (1997) 0.75
Realign committees that perform medical staff-hospital functions. Hospitals (1976) 0.75
[Acute and temporary reaction of mouse bone marrow cells following in vivo exposure to very small doses of gamma rays]. Strahlenschutz Forsch Prax (1985) 0.75
NJ hospital profits from better relations with medical staff. Hospitals (1984) 0.75
Determination of pethidinic acid and norpethidinic acid in urine by mass fragmentography after extractive alkylation. Acta Pharm Suec (1978) 0.75
Comparative pharmacokinetics of unlabeled and deuterium-labeled terbutaline: demonstration of a small isotope effect. J Pharm Sci (1988) 0.75
Mass spectrometric and gas chromatographic properties of pethidine N-oxide. Acta Pharm Suec (1975) 0.75
Investigation of the Urinary excretion of pethidine and five of its metabolites in man using selected ion monitoring. Biomed Mass Spectrom (1980) 0.75
Methaqualone metabolites. Synthesis of eight phenolic monohydroxy derivatives of methaqualone. Acta Pharm Suec (1973) 0.75
Facial memory deficits in myotonic dystrophy type 1. Acta Neurol Scand (2014) 0.75
[A room in County Council's nest. Charlotta must leave job behind in order to have an apartment. Interview by Carina Roxström]. Vardfacket (1990) 0.75
Biological fate of pethidine. Applications of gas chromatography-mass spectrometry and deuterium labelling. Acta Pharm Suec (1978) 0.75
Simultaneous determination of terbutaline and salbutamol in plasma by selected ion monitoring. Biomed Mass Spectrom (1982) 0.75
Pharmacokinetic implications of slow equilibration of terbutaline between plasma and erythrocytes. Eur J Respir Dis Suppl (1984) 0.75